Get the Stockscreener App
98.17
1.32%
1.28
After Hours:
97.78
-0.39
-0.40%
Boston Scientific Corp stock is traded at $98.17, with a volume of 4.87M.
It is up +1.32% in the last 24 hours and up +8.52% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
See More
Previous Close:
$96.89
Open:
$97.04
24h Volume:
4.87M
Relative Volume:
0.91
Market Cap:
$144.69B
Revenue:
$15.91B
Net Income/Loss:
$1.79B
P/E Ratio:
81.13
EPS:
1.21
Net Cash Flow:
$1.89B
1W Performance:
+2.31%
1M Performance:
+8.52%
6M Performance:
+25.63%
1Y Performance:
+62.94%
1-Day Range:
$96.97
$98.31
1-Week Range:
$93.20
$98.31
52-Week Range:
$59.85
$98.31
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
98.17 | 144.69B | 15.91B | 1.79B | 1.89B | 1.21 |
|
ABT
Abbott Laboratories
|
113.91 | 197.57B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
381.79 | 145.54B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
87.16 | 111.76B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.86 | 41.20B | 6.60B | 4.16B | 490.10M | 6.93 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific data supports Farapulse, Watchman FLX - Mass Device
Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research - GlobeNewswire Inc.
Boston Scientific (BSX) Receives Preliminary Approval for Shareh - GuruFocus.com
Boston Scientific reaches preliminary settlement - Investing.com India
Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation - Quantisnow
Gateway Investment Advisers LLC Decreases Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Hennion & Walsh Asset Management Inc. Buys 7,618 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Assenagon Asset Management S.A. Sells 2,948,084 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Claro Advisors LLC Purchases Shares of 2,735 Boston Scientific Co. (NYSE:BSX) - MarketBeat
Moody National Bank Trust Division Makes New $249,000 Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific (NYSE:BSX) Reaches New 52-Week HighHere's Why - MarketBeat
Boston Scientific stock soars to all-time high of $97.13 - Investing.com
Brendel Financial Advisors LLC Purchases New Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Board of the Pension Protection Fund Invests $1.02 Million in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Pines Wealth Management LLC Acquires New Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Community Trust & Investment Co. - MarketBeat
Boston Scientific expects Farapulse, Watchman to drive 2025 growth - Mass Device
Boston Scientific stock retains Buy rating on financial guidance - Investing.com
Brookstone Capital Management Buys 20,307 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance UK
Courier Capital LLC Has $2 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Why Boston Scientific (BSX) is Skyrocketing in 2025? - Insider Monkey
Salem Investment Counselors Inc. Has $17.58 Million Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
2 Newly Overvalued Stocks - Morningstar
Czech National Bank Boosts Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Here’s Why Boston Scientific Corp. (BSX) Skyrocketed Today - MSN
Boston Scientific announces acquisition of the remaining stake in Bolt Medical - MSN
Boston Scientific price target raised to $110 from $100 at Bernstein - MSN
BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement - MSN
Boston Scientific (NYSE:BSX) Raised to "Buy" at Deutsche Bank Aktiengesellschaft - MarketBeat
Deutsche Bank lifts Boston Scientific stock rating to Buy, says execution is hard - Investing.com
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth By Investing.com - Investing.com Australia
Truist maintains Boston Scientific buy rating, $110 target - Investing.com
Boston Scientific to acquire Bolt Medical - Medical Buyer
Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m - Yahoo Finance
Boston Scientific Announces Planned Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio - GuruFocus.com
Boston Scientific Co. (NYSE:BSX) Shares Sold by International Assets Investment Management LLC - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Nordea Investment Management AB - MarketBeat
Here's What to Expect From Boston Scientific's Next Earnings Report - MSN
Boston Scientific Bolt Medical acquisition ‘checks right boxes,’ JPMorgan says - MSN
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth - Investing.com
Boston Sci secures IVL tech with up to $664M Bolt buy - BioWorld Online
First Hawaiian Bank Cuts Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Surges On $900 Million Takeover Of Bolt Medical - Yahoo! Voices
Here's Why Boston Scientific Is Flirting With A Buy Zone - Investor's Business Daily
Boston Scientific acquiring Bolt Medical in $443 million deal - Yahoo Finance
Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal - AOL
Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF - CNBC
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.58%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):